RecruitingNot ApplicableNCT07306065
University of Central Florida Music Study
Scientific Proof of Music Therapy's Impact on Alzheimer's Disease
Sponsor
University of Central Florida
Enrollment
60 participants
Start Date
Aug 28, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to scientifically validate the impact of music therapy on Alzheimer's disease (AD) by analyzing molecular biomarkers in salivary exosomes. Exosomes are extracellular vesicles that carry molecular signals from brain cells, providing a non-invasive method to assess physiological changes.
Eligibility
Min Age: 50 Years
Inclusion Criteria6
- years old or older.
- adults with no mild-cognitive impairment
- adults with mild-cognitive impairment
- adults with Alzheimer's disease/ dementia.
- participant or the participant's legally authorized representative must be able to read or speak English and agree to comply with study procedures.
- pregnant women may chose to participate
Exclusion Criteria3
- years and younger
- prisoners
- unable to understand English and provide consent
Interventions
OTHERMusic intervention
UCF music concert where the participants will listen to symphonic, classical music for 1 hour.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07306065
Related Trials
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07170150135 locations
Dementia Caregivers' Link to Assistance and Resources
NCT068600351 location
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789141 locations
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
NCT07177352207 locations
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07169578120 locations